Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Pleural aspiration and pleural-fluid interpretation

Respiratory · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Pus, pleural-fluid pH at or below 7.2 in suspected infection, sepsis with a loculated collection, significant post-procedural breathlessness, hypoxaemia, haemodynamic instability or suspected bleeding requires immediate senior review and the appropriate pleural, respiratory, surgical or critical-care pathway. Treat tension pneumothorax clinically. Do not continue therapeutic aspiration through chest tightness, persistent cough, pain or worsening dyspnoea.

Synopsis

Perform and supervise pleural aspiration safely, request samples that answer the clinical question, and interpret pleural-fluid biochemistry, microbiology and cytology without losing urgent infection or malignancy pathways.

  • Define whether aspiration is diagnostic, therapeutic or both, and whether the result will change drainage, antimicrobial, cancer or heart-failure management before inserting a needle.
  • Thoracic ultrasound must be used by a trained operator to confirm fluid, identify diaphragm and solid organs, and select a contemporaneous safe site; a remote skin mark is invalid after the patient moves.
  • Check consent, laterality, indication, observations, allergies, haemostasis and antithrombotic plan, patient positioning, asepsis, equipment, sample labels and rescue arrangements through the local checklist.
  • For suspected infection, send pleural fluid for pH promptly using the locally agreed blood-gas technique without air or local-anaesthetic contamination, alongside glucose, LDH, protein and microbiology.
  • Use paired serum protein and LDH to apply Light's criteria. Meeting any one criterion classifies the fluid as an exudate, but diuresed heart failure can be misclassified and requires clinical reconciliation.
  • Frank pus establishes empyema and does not need pH to justify drainage. In non-purulent suspected infection, pH at or below 7.2 indicates high risk and generally supports intercostal drainage if safely accessible.
  • Send an adequate cytology volume under local laboratory guidance and remember that negative cytology does not exclude pleural malignancy; tumour type and repeated sampling affect yield.
  • Drain therapeutic fluid slowly, generally limiting a single attempt to about 1.5 litres, and stop sooner if chest pain, tightness, persistent cough or worsening breathlessness develops.
  • Routine post-procedure chest radiography is not required after every straightforward, ultrasound-guided aspiration in an asymptomatic patient, but symptoms, air aspiration, difficulty or suspected complication change that decision.
  • Antithrombotic interruption, laboratory containers, pH handling, competence sign-off, drainage thresholds and referral routes must follow local UK policy and the latest BTS guidance.
  • Key red flags

    Complicated pleural infection

    Purulence, positive microbiology, pH at or below 7.2, low glucose, high LDH, loculation and ongoing sepsis support complicated parapneumonic effusion or empyema. Pus or high-risk non-purulent fluid generally needs timely drainage in addition to antimicrobial treatment.

    Haemothorax pattern

    Uniformly bloody fluid after trauma, intervention or in a high-risk clinical setting requires paired pleural and peripheral haematocrit assessment and urgent specialist input. Do not dismiss progressive shock or falling haemoglobin as a traumatic tap.

    Investigation priorities

    01
    Thoracic ultrasoundFirst step

    Confirm the presence, depth and accessibility of pleural fluid, identify septation and prevent injury to diaphragm, lung and abdominal organs.

    Management branches

    PreparationProve indication and safe access

    Diagnostic or therapeutic pleural aspiration is being considered.

    1. Review imaging and define what aspiration will decide, assess urgency and alternatives, and obtain informed consent covering pain, bleeding, infection, organ injury, pneumothorax and failure to obtain an answer.
    2. Check observations, laterality, allergies, antithrombotic medicines and relevant haemostasis under local policy, while recognising that urgent sepsis may require an individual risk decision.
    3. Position the patient safely, perform contemporaneous thoracic ultrasound, identify diaphragm and viscera, and abandon bedside aspiration if no safe accessible pocket exists.
    4. Complete the local checklist with sterile equipment, labels, sample containers, monitoring and a plan for deterioration before skin preparation.

    Key medicines

    Local anaesthetic for pleural aspirationInfiltrate skin, subcutaneous tissue and periosteal tissues using the locally approved agent, concentration and maximum weight-adjusted limit, aspirating before incremental administration.Calculate the maximum permitted amount before starting, include anaesthetic already used by others, avoid intravascular injection and pleural-fluid contamination, and know the local toxicity-rescue protocol.
    Open full textbook →Answer 2 questions
    Sources and review status4 sources · checked 27 Aug 2026 · clinical review pending+
    Sources

    Sources and review status

    National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

    • British Thoracic Society pleural procedures clinical statementUltrasound, aspiration technique, sample handling, drainage limits, complications and post-procedure care.
    • British Thoracic Society pleural disease guidelinePleural-infection pH pathways, undiagnosed effusion assessment and malignant pleural disease management.
    • NICE NG12 suspected cancer recognition and referralUrgent investigation and referral context for suspected lung and pleural malignancy.
    • British Thoracic Society pleural resourcesSociety implementation resources and current pleural guidance access point; local pathways remain controlling.

    Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

    Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom